China Shineway Pharmaceutical Group Limited

CSWYF · OTC
Analyze with AI
12/31/2024
6/30/2024
12/31/2023
6/30/2023
Operating Activities
Net Income$1,060$86$33$36
Dep. & Amort.$58$11$6$6
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$222$0-$12$0
Other Non-Cash-$454-$20$14-$19
Operating Cash Flow$886$78$42$23
Investing Activities
PP&E Inv.-$130-$10-$7-$4
Net Acquisitions$0$1$0$0
Inv. Purchases-$845$0$0$0
Inv. Sales/Matur.$528$0$0$0
Other Inv. Act.$164$20$7-$0
Investing Cash Flow-$283$11$0-$4
Financing Activities
Debt Repay.$22$8$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$363-$45-$6-$17
Other Fin. Act.-$9-$5-$0$22
Financing Cash Flow-$351-$42-$6$5
Forex Effect-$48$1-$0$1
Net Chg. in Cash$251$0$36$25
Supplemental Information
Beg. Cash$5,889$830$0$0
End Cash$6,140$858$36$25
Free Cash Flow$756$67$35$20